Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid

Many breast cancer patients have both non-alcoholic fatty liver disease (NAFLD) and non-alcoholic fatty pancreas disease (NAFPD). Consequently, we hypothesized that NAFPD and NAFLD were associated with breast cancer, and aimed to build a novel risk-stratification scoring system based on it. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chuntian, Yan, Yonghao, Su, Liyang, Chen, Debo, Zhang, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974397/
https://www.ncbi.nlm.nih.gov/pubmed/35434374
http://dx.doi.org/10.1515/med-2022-0462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974397/
https://www.ncbi.nlm.nih.gov/pubmed/35434374
http://dx.doi.org/10.1515/med-2022-0462

Ejemplares similares